Orfiril Long (Sodium Valproate)

Sodium Valproate, the active ingredient in Orfiril Long, is a carboxylate anticonvulsant presented as a oral tablet for oral use. It treats epilepsy and related seizure disorders in adults and children. GNH USA supplies Orfiril Long as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orfiril Long as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orfiril Long is an anticonvulsant that is used across several seizure‑related conditions.

- Epilepsy: Helps control generalized tonic‑clonic seizures. - Absence seizures: Reduces the frequency of brief staring episodes. - Myoclonic seizures: Diminishes sudden, brief muscle jerks. - Lennox‑Gastaut syndrome: Assists in managing multiple seizure types in this severe epilepsy syndrome. - Bipolar disorder (off‑label): May stabilize mood in some patients under specialist supervision.

Sodium ​  ​         …   t   ...  g  ewline   ewline  ewline  ....  ewline  ewline  ewline  ewline  ewline \n

    ewline ".  "  ewline \

{}